Skip to content
Drug recall · FDA · Published June 29, 2020

RemedyRepack Inc. recalls Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA

RemedyRePack recalls 200mg Carbamazepine tablets with failed dissolution testing. This may affect medication effectiveness. Contact for return instructions.

🇺🇸 FDA recall #D-1387-2020DrugRemedyRePack ›
Take action

Contact the company & request your remedy

Recalling firmRemedyRepack Inc.625 Kolter Dr Ste 4, N/A · Indiana, PA 15701-3571
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

RemedyRePack is recalling 200mg Carbamazepine tablets that failed dissolution testing during stability checks. This could mean the medication doesn't work as intended, risking treatment failure for people using it. Read more at govinfonow.com/recall/36995-remedyrepack-carbamazepine-tablets-recall-failed-dissolution-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/36995-remedyrepack-carbamazepine-tablets-recall-failed-dissolution-testing · Updated October 5, 2026 · FDA enforcement record: FDA #D-1387-2020

Cite this page

“RemedyRePack Carbamazepine Tablets Recall: Failed Dissolution Testing.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36995-remedyrepack-carbamazepine-tablets-recall-failed-dissolution-testing. Based on FDA recall #D-1387-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1387-2020%22&limit=1).

Why it’s dangerous

The tablets failed dissolution testing, meaning they don't dissolve properly in the body. This could lead to the medication not working effectively, potentially causing treatment failure for conditions like seizures.

Who’s affected

People prescribed Carbamazepine by a doctor who received this specific tablet batch. Those with seizure disorders or other conditions requiring this medication are most at risk.

How to tell if you have this one

Check for the brand RemedyRePack, 200mg tablets, 100-unit dose per box, NDC 70518-2489-00 for box or 70518-2489-01 per unit. The lot number B0796217-020920 with expiration 02/28/2021.

  • Brand
    RemedyRePack
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Verify the product label matches the described batch and expiration date to confirm if it's recalled.

✎ GovInfoNow

Questions people ask

Is this medication dangerous if taken?

The recall is due to failed dissolution testing, which may affect medication effectiveness. It is not immediately dangerous but could lead to treatment failure if the medication doesn't work properly.

How do I know if I have the recalled product?

Check for RemedyRePack 200mg tablets with NDC 70518-2489-00 (box) or 70518-2489-01 (unit), lot B0796217-020920, expiring 02/28/2021.

What should I do if I have this product?

The recall does not specify a remedy. Check with your doctor or pharmacist for guidance on whether to continue using or return the medication.

Take action

Contact RemedyRePack

We’ve drafted a message you can send RemedyRePack to request your refund or repair — edit it as you like.

Subject: Recall D-1387-2020 — RemedyRePack RemedyRePack

Hello,

I own a RemedyRePack that is covered by recall D-1387-2020 from RemedyRePack.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1387-2020 (June 29, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1387-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA